We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+18.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$316M
AUM Growth
+$17.7M
Cap. Flow
-$18.4M
Cap. Flow %
-5.81%
Top 10 Hldgs %
52.21%
Holding
58
New
3
Increased
32
Reduced
6
Closed
6

Top Buys

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$8.34M
2
MODN
MODEL N, INC.
MODN
+$5.73M
3
GMED icon
Globus Medical
GMED
+$5.47M
4
DVAX
Dynavax Technologies
DVAX
+$4.33M
5
TLGT
Teligent, Inc
TLGT
+$3.92M

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$24.6M
2
SPNC
Spectranetics Corp
SPNC
+$8.36M
3
SAGE
Sage Therapeutics
SAGE
+$7.39M
4
IMMU
Immunomedics Inc
IMMU
+$7.35M
5
AMED
Amedisys
AMED
+$5.81M

Sector Composition

Rank Sector Weight
1 Healthcare 82.06%
2 Communication Services 4.03%
3 Energy 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.96B
$26.8M 8.49%
2,407,930
-271,341
-10% -$2.64M
ATRC icon
2
AtriCure
ATRC
$1.92B
$23.1M 7.32%
1,033,736
+74,878
+8% +$1.69M
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$18.3M 5.81%
1,311,514
-737,129
-36% -$7.35M
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
$18.1M 5.72%
1,469,461
+897,832
+157% +$8.34M
HBIO icon
5
Harvard Bioscience
HBIO
$27.5M
$15.4M 4.89%
411,628
+54,408
+15% +$1.61M
OMCL icon
6
Omnicell
OMCL
$1.61B
$15.2M 4.82%
298,219
+19,925
+7% +$954K
MODN
7
DELISTED
MODEL N, INC.
MODN
$12.7M 4.03%
851,708
+428,497
+101% +$5.73M
NKTR icon
8
Nektar Therapeutics
NKTR
$2.39B
$12.1M 3.82%
33,546
+2,200
+7% +$688K
ENTL
9
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$11.7M 3.7%
632,737
+120,321
+23% +$2.08M
SHPG
10
DELISTED
Shire pic
SHPG
$11.4M 3.61%
74,470
+4,951
+7% +$776K
TLGT
11
DELISTED
Teligent, Inc
TLGT
$9.95M 3.15%
148,334
+53,488
+56% +$3.92M
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$9.45M 2.99%
562,377
+37,868
+7% +$616K
LGND icon
13
Ligand Pharmaceuticals
LGND
$5.76B
$8.63M 2.73%
101,544
+1,159
+1% +$91.8K
MDCO
14
DELISTED
Medicines Co
MDCO
$8.16M 2.58%
220,300
+81,757
+59% +$3.01M
HALO icon
15
Halozyme
HALO
$9.79B
$7.74M 2.45%
445,846
+29,267
+7% +$396K
VCYT icon
16
Veracyte
VCYT
$3.7B
$7.38M 2.34%
841,959
+87,399
+12% +$711K
HRTX icon
17
Heron Therapeutics
HRTX
$93.9M
$6.36M 2.01%
393,505
+26,115
+7% +$410K
DVAX
18
DELISTED
Dynavax Technologies
DVAX
$5.89M 1.86%
+273,930
New +$4.33M
KTWO
19
DELISTED
K2M Group Holdings, Inc
KTWO
$5.84M 1.85%
275,173
+3,678
+1% +$85.2K
NVRO
20
DELISTED
NEVRO CORP.
NVRO
$5.44M 1.72%
59,905
+547
+0.9% +$46.8K
QDEL icon
21
QuidelOrtho
QDEL
$1.14B
$5.37M 1.7%
122,509
+48,308
+65% +$1.68M
GMED icon
22
Globus Medical
GMED
$10.7B
$5.32M 1.68%
+179,016
New +$5.47M
XENT
23
DELISTED
Intersect ENT, Inc
XENT
$5.3M 1.68%
170,197
-103,448
-38% -$3.06M
NXTM
24
DELISTED
NxStage Medical Inc.
NXTM
$5.07M 1.6%
183,592
+12,014
+7% +$320K
BLUE
25
DELISTED
bluebird bio
BLUE
$4.96M 1.57%
2,786
+178
+7% +$249K
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, First Light Asset Management held 58 positions worth $316M, up 5.9% from $298M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

First Light Asset Management withdrew a net $18.4M in Q3 2017, closing 6 positions and reducing 6 holdings. Its most notable exit was Akorn Inc, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 75% a quarter earlier, followed by Communication Services and Energy.

Against the trend, First Light Asset Management opened a new position in Globus Medical worth $5.32M.

  • First Light Asset Management's largest Q3 2017 buy was Globus Medical: 179,016 shares worth $5.32M.
  • First Light Asset Management added most to Array Biopharma Inc in Q3 2017, an estimated $8.34M increase.
  • First Light Asset Management's biggest Q3 2017 reduction was Immunomedics Inc, cutting an estimated $7.35M.
  • First Light Asset Management fully exited Akorn Inc in Q3 2017, selling an estimated $24.6M.
  • First Light Asset Management's ten largest holdings make up 52% of its $316M portfolio in Q3 2017.
  • First Light Asset Management opened 3 new positions and closed 6 in Q3 2017.
  • First Light Asset Management's portfolio value rose 5.9% quarter-over-quarter to $316M.

Based on First Light Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.